ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0060003;copper ion export;10.0;0.9326813400603323;0.8815816818910864;9.56398573135455;101.53169440817886;9.083926447120524;0.0033981744392491903;0.8797934328124444;[ATP7B]
GO:1990090;cellular response to nerve growth factor stimulus;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;97.48528473772916;5.9928839937622085;0.003262744749111514;0.6295966787287501;[CALCA, AKT1]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, DUSP6, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, IQGAP3, NTF3, CCL19, DRD4, EGF, CSPG4, PKN1]
GO:0050796;regulation of insulin secretion;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;205.48125160941495;4.61801832846594;0.006877272570246766;0.6324062972578516;[KCNG2, TNF, GHSR, IFNG, IL1B, BLK, KCNA5, CNR1, CCL5]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[PHB2, SLC8A1, MYB, AKT1, ACTN4, ATP1B1, CLDN3, ABCB4, PSEN2, EGR1, TGFB1, CAV1, NR4A2, CXCL12, NOX4, CD24, MYOCD, KCND2, AGTRAP, TGFBR3, IL1B, TLR2, CXCR4, KCNA5, PTGS2, PAK1, TEK]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[EHMT2, SLA2, PHB2, MYB, HOXA7, MEF2C, HOXB4, HOXB3, ATF3, PRDM16, ELANE, PKIG, EZH2, PAWR, PAX5, PAX2, AES, MMP12, FLNA, NR1H2, LGR4, GMNN, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, RFC1, XCL1, RBBP8, E2F7, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, DPF3, RUNX2, PCBP3, EGR1, BCL11A, IFNA2, PTPRK, XPO1, CD36, IL1B, ARID4A, BASP1, CCNE1, CALCA, TGFB1, CBX4, CAV1, HMGA1, NR4A2, MXD1, HMGB2, MYOCD, IFNG, ELF3, FBP1, PFDN5, MEIS2]
GO:0051482;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;292.0931097099921;6.139487467954083;0.009776093515261451;0.7620939872166814;[CALCA, F2R, C3AR1, AGTR1, GPR18, GPR157, F2RL3]
GO:0033137;negative regulation of peptidyl-serine phosphorylation;10.0;0.8933024483968273;0.861892236059334;9.56398573135455;780.3281191277907;6.518977089658987;0.026116879897493853;0.7486218033895181;[CAV1, PAQR3, DMD]
GO:0034622;cellular protein-containing complex assembly;5.0;0.4844594654465739;0.5324707445842072;6.524578394297898;40.42272244673708;3.0306614991070955;0.0013529121422039536;0.4452291818654298;[, NUP107, PADI4, NUP205, PDGFC, ARHGAP6, CHAF1B, CHAF1A, BRD2, HLA-DMA, HLA-DMB, DMD, GSN, GTF2H1, CENPK, CENPL, GMNN, DACH1, RUVBL1, SNRPG, SNRPE, SNRPF, LSM3, HLA-DRA, VBP1, NDUFC2, MCM2, NDUFB6, NDUFB4, NDUFB3, NDUFB2, NDUFB1, EIF4H, NDUFA8, NDUFA6, NDUFA3, NDUFA2, RAD51, EIF3D, CCNH, SNRPD2, SNRPD1, FBXO5, SNRPD3, PTK2, AHCTF1, CD3E, CCT2, RAD51C, MIS12, UQCR10, RPA1, RPA3, NDUFAB1, NDUFA11, NDUFB10, NDUFB11, ADRB2, NLRP3, H1FX, MYH11, TGFB1, EIF2S1, NASP, TCF4, HMGB2, DNM2, TGFBR3, NDUFS8, NDUFS7, NDUFS4, NDUFS3, HIST1H2BK, TAF9, HSPD1, EGF, TTC19, RBMX]
GO:0015701;bicarbonate transport;7.0;1.0;0.8509193652572005;9.628524252492122;31.887457555831563;6.015873511986907;0.0010672445075450394;0.6585714164269392;[SLC4A3, SLC4A7, CA4, SLC26A8, SLC26A7, SLC26A3]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, TNF, TCL1A, AKT1, IFNA14, IFNA16, MIF, IFNG, IFNA10, PTGS2, PAK1, NTF3, IFNA21, TGFB1, CAV1]
GO:0002092;positive regulation of receptor internalization;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;393.55365953464764;6.599019797332524;0.013171886809326083;0.7337148045016781;[EGF, NTF3, SELE]
GO:2000251;positive regulation of actin cytoskeleton reorganization;9.0;1.0;0.896240625180289;9.628524252492122;130.7363647434596;6.8867018697843045;0.004375628472874139;0.7484268790654467;[NRP1, NTF3, STAP1, TEK]
GO:0034220;ion transmembrane transport;5.0;0.44800904580126355;0.514245534761552;6.183841758890227;26.332710660334534;2.96803432163749;8.813321279004005E-4;0.4420264250971726;[SLC35B3, AQP9, SLC4A3, PHB2, SCN1A, SLC6A16, SLC11A1, SLC6A15, CACNA2D3, SLC6A13, CLDN4, KCNQ1, SLC22A4, ATP5I, SLC30A10, ATP5O, ATP5L, GJC1, ANKH, KCNMB3, KCNN3, SCN3A, ABCA1, SLC6A6, FXYD6, GABRB1, GRIK3, SLC7A11, JPH2, CCR5, KCND2, ZDHHC17, TMEM37, SLC7A5, SLC7A7, SLC7A8, CLDN17, SGK1, CAPS2, KCNA5, COX5A, ANO10, SLC17A6, CCL19, GABRE, SLC17A3, GABRA5, KCNG2, STEAP4, DENND5B, SLC8A1, SLC16A3, KCNH1, CHRNB4, SLC38A1, F2R, ATP1B2, ATP1B1, ATP5J2, KCNE3, KCNE4, HVCN1, SLC41A2, SLC1A3, SLC38A11, CACNA1F, SLC1A6, SLC38A6, CLCA4, GRIA4, SLC26A8, SLC26A7, SLC26A3, KCNK5, ATP2A3, SLC40A1, FASLG, ATP7B, SLC36A1, TRPC7, SLC13A1, TRPC3, TRPC1, NDUFS7, XCL1, SLC24A2, SLC24A1, SLC24A4, SLC3A1, LRP2, SLC35A3, NDUFA4, SLC12A1, KCNJ15, KCNJ16, SLC4A7, P2RX5, P2RX1]
GO:0015680;intracellular copper ion transport;9.0;1.0;0.896240625180289;9.628524252492122;54.57636043096932;8.67846133901236;0.001826621668089006;0.8400575416471059;[ATP7B]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CDA, KCNG2, TCL1A, TNFSF11, MIF, OLFM4, CLDN3, BLM, MGST1, CD79B, CD79A, NACC2, CAV1, CD3G, CD3E, KCND2, ARG1, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, KCNA5, NLRC4, SAMHD1, PLN, GCH1, RAD51, P2RX1, GOPC, RBMX]
GO:0007268;chemical synaptic transmission;7.0;0.7369933605727446;0.7194160455435727;8.663443356448536;23.173347188538074;3.922001705478042;7.755910757418987E-4;0.5514907148670789;[CHRM2, GABRB1, CHRM1, GRIK3, GRM5, CHRNB4, KCND2, NPY1R, SLC5A7, SLC1A3, SLC1A6, GJC1, SV2A, HRH4, KCNMB3, SLC17A6, GABRE, DRD4, EGR3, HTR1E, GABRA5, PCDHB15, PCDHB14, PCDHB10, P2RX1, PNOC, PCDHB16, PLP1, PCDHB4, PCDHB8, GPR19]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[HP, TNFAIP3, SLC8A1, IL18RAP, MYB, PDGFRB, ANXA1, DUSP1, ARG1, PAX2, ADAM9, PCNA, KCNA5, FOXO1, PDGFD, SDC1, EZH2]
GO:0045779;negative regulation of bone resorption;7.0;1.0;0.8509193652572005;9.628524252492122;83.00611842489866;7.292166977892469;0.002778140083024753;0.7238411236270654;[CALCA, TNFAIP3]
GO:0045778;positive regulation of ossification;5.0;0.8436909121759173;0.712086467948879;9.377209824211215;41.729731686539594;5.370354380416217;0.0013966565652281952;0.5648811846224242;[CALCA, ADRB2, SLC8A1, IL6R, MEF2C, TGFB1, JAG1, RUNX2, LTF]
GO:0086091;regulation of heart rate by cardiac conduction;8.0;1.0;0.875;9.628524252492122;61.172773623059015;6.193554689224359;0.002047397681241798;0.6917386748366816;[DSP, JUP, KCNE3, KCNQ1, CAV1, KCNA5]
GO:0050965;detection of temperature stimulus involved in sensory perception of pain;6.0;1.0;0.8231203125901445;9.628524252492122;60.1825293085583;7.069023426578259;0.002014255095197483;0.6846304993685643;[CALCA, CXCL12, EPHB1]
GO:0034613;cellular protein localization;4.0;0.4527475610289664;0.4763737805144832;6.332687386487793;26.8334375525691;2.8773505203955967;8.980910063585456E-4;0.39714783942351395;[, NUP107, AKT1, SEH1L, NUP85, NUP88, JUP, EZH2, LRRC4, MMP12, FLNA, DMD, CSE1L, TNF, CDH1, LAMP2, CD177, RAB32, PKP3, SLC27A2, LIN7A, NACC2, LRRK2, HHEX, NLGN1, TSPAN33, DNAJA3, VPS41, PAQR3, GOLPH3L, ESCO2, TSPAN5, CD24, NRP1, PTPRK, BRCA2, TRAM2, XPO1, RAB33B, MIS12, HSD17B4, RANBP2, RANBP1, RPA1, RAMP1, SCARB2, CELSR1, TSC2, ATP1B1, HGS, VCL, NUP155, CAV1, TNFAIP3, NUP62, NUP133, NUP54, HSPD1, NUP35, RAN]
GO:0015677;copper ion import;9.0;0.8933024483968273;0.8428918493787028;9.427853557029971;21.372061049954535;7.697632086000634;7.153036497357847E-4;0.7898978880348613;[STEAP4, ATP7B]
GO:0070509;calcium ion import;9.0;0.8259837884571596;0.8092325194088689;9.36615998802463;37.619827487335996;6.088194173566533;0.0012591017703544919;0.7075911583464645;[CACNA1F, SLC8A1]
GO:0014047;glutamate secretion;10.0;0.9326813400603323;0.8815816818910864;9.574457031221845;161.52301102016722;6.8867018697843045;0.005406029817572731;0.7674272657460779;[SLC1A3, SLC1A6]
GO:0055075;potassium ion homeostasis;8.0;0.8933024483968273;0.8216512241984136;9.533214072687796;71.74727346628734;6.409777797693995;0.0024013166745626502;0.7027963346592216;[SLC12A1, KCNA5, ATP1B2, ATP1B1]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MEF2C, CLDN7, AGTR1, ATF3, HHLA2, IQGAP3, PDGFD, PDGFC, ELANE, LYN, CDC6, CDKN1A, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, PAX2, MMP12, HBEGF, PTAFR, KCNA5, PTGS2, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB2, LRG1, HLA-DPB1, CHRM1, TNF, CTGF, FGF5, PYCARD, CDH3, F2R, MSH6, CD274, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, BCL6, FASLG, TNFSF13B, XCL1, CX3CR1, SMARCD3, LRP2, CCL5, KLF5, DNAJA3, TCL1A, EDNRB, SKP2, ICOSLG, FLT3LG, MIF, RUNX2, BTC, TGFA, PKHD1, EGR1, EGR3, TNFSF12, PTK2, BST1, CD28, CD24, CD320, NRP1, NRP2, PRL, CD3E, ESM1, CCR2, RHOG, PDCD1LG2, AVPR1A, CEACAM6, IL1B, KIT, GNAI2, PAK1, CXCR2, LILRB2, CD80, SIRPG, IL6R, PDGFRB, GHSR, CCNE1, PRTN3, C5AR1, LTBP3, TGFB1, CAV2, NR4A1, LIN28A, HMGB2, TNFAIP3, LAMC2, CXCL5, MYOCD, GLP2R, MMP9, TGFBR3, IFNG, NDUFS4, LTF, DLL1, S1PR3, EGF, MEIS2, TSHR, CD4, CD6, TEK]
GO:0007196;adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;85.0206884702681;7.57984905034425;0.002845565929447937;0.7838744581139225;[GRM5, GRIK3]
GO:0048812;neuron projection morphogenesis;7.0;0.6547035408479693;0.6782711356811852;8.502512989635898;62.99970935475633;4.360973225476049;0.002108543576046295;0.5739397388140403;[STMN1, EPHB1, SDC2, GP5, PTK2, NR4A2, LRFN4, OGN, NRP1, LRRK2, DCC, PAX2, DNM2, SGK1, DSCAML1, NLGN1, LRP2, PAK1, NTF3, SLITRK6, LINGO1, WEE1]
GO:0007595;lactation;6.0;1.0;0.8231203125901445;9.628524252492122;25.956233089099676;5.9928839937622085;8.687317623989867E-4;0.6295966787287501;[ABCB4, CAV1, PRL, ATP7B]
GO:0045664;regulation of neuron differentiation;7.0;0.5064924996362321;0.6041656150753165;7.722354432086322;62.256296269576055;3.3619766685088743;0.0020836622091136505;0.5228510084326481;[CYFIP1, CPNE5, EDNRB, AKT1, MEF2C, PAQR3, EPHA3, SDC2, LYN, JAG1, BCL11B, PLK2, PTK2, EZH2, ITM2C, ROBO2, NRP1, RGMA, IL1B, PAK1, NTF3, SCARB2, SEMA5B, PLXND1, TNR, SYT2, CXCL12, LIN28A, BCL6, TCF4, LRRK2, DCC, DNM2, NLGN1, LRP1, DLL1, RAB21, CNR1, S1PR5, LINGO1, SEMA4B, MEIS1]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, CHL1, MEF2C, F2R, MSH2, NAIP, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, WFS1, GABRA5, NR4A2]
GO:0006813;potassium ion transport;7.0;0.7980440201809971;0.7499413753476991;9.310070521373587;34.16983994150393;4.61801832846594;0.001143633791982704;0.587085037334763;[KCNK5, KCNG2, KCNH1, KCND2, ATP1B2, ATP1B1, KCNQ1, SLC24A2, SLC24A4, KCNE3, KCNE4, SLC1A3, KCNA5, KCNMB3, KCNN3, SLC12A1, KCNJ15, KCNJ16]
GO:0098712;L-glutamate import across plasma membrane;12.0;0.9326813400603323;0.9144609826203107;9.600353375525426;1074.08790550917;7.9853141584524145;0.03594875558103501;0.8564896500084854;[SLC1A3, SLC1A6]
GO:0070588;calcium ion transmembrane transport;9.0;0.7140352122741334;0.7532582313173557;9.078477915572849;116.6808485568922;4.562137870071484;0.003905202995253044;0.629548568016852;[DENND5B, ATP2A3, FASLG, PHB2, SLC8A1, JPH2, CCR5, TRPC7, TRPC3, TRPC1, F2R, CACNA2D3, TMEM37, XCL1, SLC24A2, SLC24A1, SLC24A4, CACNA1F, CCL19]
GO:0071435;potassium ion export;10.0;0.9326813400603323;0.8815816818910864;9.571365838652174;121.72212082045542;7.379178354882098;0.004073929841064025;0.7926125360964777;[KCNQ1, KCNA5]
GO:0032147;activation of protein kinase activity;11.0;0.6799073451904818;0.7723826249249031;9.164951513576677;1096.8683293671154;4.034070439870987;0.03671119586651001;0.6387315022281249;[, TNF, AKT1, PROK2, TNFSF11, MAP2K2, SLC11A1, F2R, ADAM9, CALCA, C5AR1, FPR1, TGFA, ADRB2, IQGAP3, PRKAR2B, PDGFC, DRD4, TNFRSF10B, CSPG4, LRRK2, GHR, MAP4K1, DUSP6, IL1B, KIT, CHI3L1, TLR4, CXCR4, PAK1, NTF3, CCL19, EGF, PKN1]
GO:0050856;regulation of T cell receptor signaling pathway;7.0;0.8653626801206646;0.7836007053175329;9.461470167828956;68.86251036091213;6.193554689224359;0.0023047662495439825;0.6676580400938822;[CACNA1F, LGALS3, UBASH3A, TRAT1, PVRIG, PAWR, CEACAM1]
GO:0032148;activation of protein kinase B activity;12.0;1.0;0.9481203125901445;9.628524252492122;1099.1709144601095;6.311337724880743;0.03678826131738048;0.770882417347765;[NTF3, AKT1]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD80, IFNA2, TREM2, CD3E, GHR, GRM5, CD36, IL6R, MIF, IFNG, BANK1, KIT, HBEGF, TGFA, CCL5, NTF3, STAP1, LYN, TGFB1, ACE, EGF, GH1, CD4, CSPG4, CD24]
GO:2000651;positive regulation of sodium ion transmembrane transporter activity;10.0;0.8259837884571596;0.8282329060895002;9.464221201200845;676.006430662935;7.212124270218933;0.022625326867999323;0.7840693824379941;[DMD, ACTN4, ATP1B1, DRD4, DNM2]
GO:0019229;regulation of vasoconstriction;7.0;0.7369933605727446;0.7194160455435727;9.310070521373587;55.827436365827396;5.500407508664414;0.0018684940537334635;0.6322104610454062;[DOCK5, CHRM1, PTAFR, KCNA5, PTGS2, AKT1, ACE, CAV1, F2R, AVPR1A, P2RX1, AGTR1]
GO:0050732;negative regulation of peptidyl-tyrosine phosphorylation;10.0;0.7980440201809971;0.8142630219514189;9.446202695698167;781.0212663083519;5.926926025970411;0.02614007890983527;0.7183442844592942;[PPP2R1A, NTF3, CAV1]
GO:0050908;detection of light stimulus involved in visual perception;7.0;1.0;0.8509193652572005;9.628524252492122;116.24341103924905;6.943860283624253;0.003890562355205735;0.7060287030842711;[SEMA5B, CACNA1F]
GO:0060372;regulation of atrial cardiac muscle cell membrane repolarization;9.0;0.8653626801206646;0.8289219652406215;9.474373572664863;48.25689803028158;7.8311634786251565;0.001615114948684907;0.7967266896635242;[KCNQ1, FLNA, KCNA5]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[TAGLN, SGCE, BASP1, DMD, MEF2C, EGR3, CXCL10, ITGA7, HBEGF]
GO:0010881;regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion;11.0;1.0;0.9324289523296623;9.628524252492122;219.4584201917244;6.8867018697843045;0.007345075824061613;0.7846152062148197;[PLN, DMD, SLC8A1]
GO:0015810;aspartate transmembrane transport;10.0;1.0;0.9152410118609203;9.628524252492122;323.5081491563933;8.16763571524637;0.010827526613832551;0.8329342821725234;[SLC1A6]
GO:0035249;synaptic transmission, glutamatergic;8.0;1.0;0.875;9.628524252492122;25.73829654599903;6.444869117505266;8.61437622431563E-4;0.7045909063862833;[P2RX1, GRIK3, SLC17A6]
GO:1901385;regulation of voltage-gated calcium channel activity;10.0;0.811012628672052;0.8207473261969463;9.474373572664863;230.24677907309362;6.139487467954083;0.007706152486928402;0.7292146864874571;[KCNE3, PDE4B, DMD, GEM, DRD4]
GO:0006882;cellular zinc ion homeostasis;10.0;1.0;0.9152410118609203;9.628524252492122;329.3407122754199;6.375876246018314;0.011022737252460356;0.7413036195908642;[ATP7B]
GO:0043267;negative regulation of potassium ion transport;8.0;0.7436939687323844;0.7468469843661922;9.0306872517365;68.61495707395616;6.444869117505266;0.00229648086381306;0.7045909063862833;[KCNE3, CAV1, KCNA5]
GO:0043029;T cell homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;22.00128503895464;6.444869117505266;7.363632103827933E-4;0.6805102716434839;[TGFB1, SLC46A2, TNFSF14, CACNA1F, CORO1A, SIT1]
GO:0001984;artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure;9.0;1.0;0.896240625180289;9.628524252492122;42.452259184769396;9.777073627680469;0.001420838910361415;0.896240625180289;[CALCA]
GO:0006878;cellular copper ion homeostasis;10.0;0.8653626801206646;0.8479223519212526;9.523163736834295;186.04478652569694;7.138016298065211;0.006226751575577643;0.7802794972956796;[ATP7B, CCDC22]
GO:0098656;anion transmembrane transport;6.0;0.49195317825426244;0.5690969017172758;6.85593553025234;41.41505613938169;4.2676852910524925;0.0013861246578544264;0.541369936842231;[SLC35B3, AQP9, SLC4A3, SLC16A3, SLC38A1, SLC6A16, SLC6A15, CLDN4, SLC1A3, SLC38A11, SLC1A6, ANKH, SLC38A6, CLCA4, ABCA1, SLC6A6, SLC26A8, SLC26A7, SLC26A3, GABRB1, SLC7A11, SLC36A1, SLC13A1, SLC7A5, SLC7A7, SLC7A8, CLDN17, SLC3A1, LRP2, SLC17A6, GABRE, SLC35A3, GABRA5, SLC12A1, SLC4A7]
GO:0060291;long-term synaptic potentiation;8.0;1.0;0.875;9.628524252492122;145.7697243391103;5.948432231191374;0.004878781489395318;0.6792031009335148;[SLC24A2, SLC24A1, NLGN1, PLK2, TNR]
GO:0051967;negative regulation of synaptic transmission, glutamatergic;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;135.86833888550652;7.069023426578259;0.004547391028931578;0.7365101867784198;[GRIK3]
GO:0060292;long term synaptic depression;8.0;1.0;0.875;9.628524252492122;145.80791725818347;7.004484905440688;0.004880059772025301;0.7332096838060964;[SLC24A2, SLC24A1, PLK2]
GO:0051209;release of sequestered calcium ion into cytosol;14.0;0.7980440201809971;0.874941375347699;9.527428135620752;522.9340415463636;5.9928839937622085;0.01750213176047399;0.7823957313958061;[F2R, FASLG, JPH2, XCL1, CCL19, CCR5]
GO:0035235;ionotropic glutamate receptor signaling pathway;7.0;0.8653626801206646;0.7836007053175329;9.310070521373587;27.195621953761602;6.558197802812269;9.102129923216596E-4;0.6863059058804069;[GRIK3, GRIA4]
GO:0060316;positive regulation of ryanodine-sensitive calcium-release channel activity;14.0;1.0;0.9759193652572005;9.628524252492122;2786.515379930216;7.697632086000634;0.09326216206523613;0.8695766281117727;[JPH2]
GO:0007189;adenylate cyclase-activating G-protein coupled receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.249034630787218;56.871035456649615;5.192106149009898;0.0019034223761250782;0.6617651750982834;[CALCA, CALCRL, PTGER2, ADRB2, GNAI2, PLN, PTGDR, ABCA1, LHCGR, PTGIR, TSHR, MC3R, ADCY9, RAMP1, LGR4]
GO:0060314;regulation of ryanodine-sensitive calcium-release channel activity;10.0;0.8933024483968273;0.861892236059334;9.56398573135455;427.81060936749446;6.518977089658987;0.014318436090978222;0.7486218033895181;[JPH2, PLN, DMD]
GO:0038180;nerve growth factor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;27.195621953761602;7.292166977892469;9.102129923216596E-4;0.7238411236270654;[SORT1, NTF3, CORO1A]
GO:0007218;neuropeptide signaling pathway;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;26.976932752798508;5.123113277522946;9.028936615729279E-4;0.5851165638517994;[CALCA, SORT1, NPY1R, GPR84, SORCS3, PNOC, PROK2, GPR19]
GO:0051453;regulation of intracellular pH;10.0;0.7192862368539868;0.7748841302879137;9.242861771680136;143.07278219841277;5.407625775213448;0.004788517263036519;0.6917872454856517;[LRRK2, FASLG, SLC4A3, SLC11A1, AVPR1A, SLC4A7, SLC26A8, SLC26A7, SLC26A3]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[TMEM100, HHEX, FCER2, PSEN2, KCNA5, DLL1, PLN, S1PR3, TGFB1, JAG1, KRT19]
GO:0043043;peptide biosynthetic process;6.0;0.6467165523344657;0.6464785887573774;8.663443356448536;211.48261067784418;4.284012184339921;0.007078132657394585;0.5422048949242282;[AKT1, ELANE, COPS5, EIF4H, DMD]
GO:0050804;modulation of chemical synaptic transmission;6.0;0.5214636594213398;0.5838521423008144;7.2437010612611035;27.32355736088522;3.9162874042146036;9.144948752636959E-4;0.5233994325676684;[TNR, MEF2C, CHRNB4, F2R, KMO, SLC1A3, ADRB2, DRD4, EGR2, PLK2, MCTP1, LRRK2, GRIK3, NRGN, GRM5, SORCS3, IL1B, KIT, CX3CR1, SLC24A2, SLC24A1, NLGN1, RETN, PTGS2, GNAI1, GNAI2, CNR1, NTF3, NLGN4Y, LILRB2]
GO:0086050;membrane repolarization during bundle of His cell action potential;9.0;1.0;0.896240625180289;9.628524252492122;83.43301858875778;9.777073627680469;0.0027924280473239135;0.896240625180289;[KCNA5]
GO:2000288;positive regulation of myoblast proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;7.57984905034425;0.002123883781187112;0.710754145523778;[KCNA5, MEIS2]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[CXCL13, TNF, CTGF, CXCL16, FGF5, VSTM1, TNFSF11, MEF2C, IFNA14, IFNA16, FLT3LG, MIF, BTC, IFNA10, CALCA, TGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB1, JAG1, TNFSF14, TNFSF12, INHBA, PPBP, GH1, CXCL10, CXCL11, CXCL12, PNOC, OGN, CD320, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, CXCL1, FASLG, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, IFNG, IL1B, XCL1, HBEGF, CCL13, NLGN1, CLEC12B, RETN, CCL8, TTR, GPNMB, CCL7, CCL5, CCL4, NTF3, CCL2, CCL1, CCL19, CCL18, CCL23, EGF, CCL20, CMTM2, FCGR2B, PF4, IL17A]
GO:1902083;negative regulation of peptidyl-cysteine S-nitrosylation;9.0;1.0;0.896240625180289;9.628524252492122;446.489693504691;8.16763571524637;0.014943608226965869;0.8139338954918922;[DMD]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[MYLK, LGALS3, C3AR1, AKT1, IL1R1, ACTN4, PFN1, FPR2, PLA2G7, EPB41L5, PDGFD, PDGFC, S100A14, ELANE, LYN, CCR1, TNFSF14, PLK2, PPBP, PTK2, NOX4, NRP1, NRP2, CCR6, CCR2, ANXA1, ANXA3, GAB1, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CCL20, PF4, SEMA5B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, IL6R, PDGFRB, F2R, ADAM9, CD274, CD151, C5AR1, CORO1A, TGFB1, CXCL10, CXCL11, CXCL12, DOCK5, CXCL6, CXCL9, TNFAIP6, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, MMP9, IFNG, XCL1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, EGF, SEMA4B, TEK]
GO:0086052;membrane repolarization during SA node cell action potential;9.0;1.0;0.896240625180289;9.628524252492122;83.43301858875778;9.777073627680469;0.0027924280473239135;0.896240625180289;[KCNA5]
GO:0046716;muscle cell cellular homeostasis;5.0;1.0;0.7902410118609202;9.628524252492122;31.94563669038233;6.781341354126479;0.0010691917108206317;0.6370391240755715;[LAMP2, DMD]
GO:0090630;activation of GTPase activity;7.0;1.0;0.8509193652572005;9.628524252492122;49.337455126924546;5.2552850506314295;0.0016512802222712962;0.6196748871422394;[CXCL13, NTF3, EVI5, RHOG, TBC1D9, TBCK]
GO:0045986;negative regulation of smooth muscle contraction;8.0;0.7508913569872202;0.7504456784936101;8.98189708756707;66.40311154199819;7.138016298065211;0.002222452384390169;0.7400384854347593;[DOCK5, CALCA, CALCRL, ADRB2, PTGS2]
GO:0055024;regulation of cardiac muscle tissue development;7.0;0.6835726970475526;0.6927057137809769;8.83001655627435;43.05278353301431;5.528578385631111;0.0014409379198603472;0.6336511210035629;[DLL1, PAK1, JPH2, MEF2C, MYOCD, TGFB1, TGFBR3, MEIS1]
GO:0034765;regulation of ion transmembrane transport;6.0;0.45556283921517005;0.5509017321977295;6.676594601596523;33.03735142972539;3.697140432584879;0.0011057304206669666;0.512192246247148;[, KCNG2, SLC8A1, AKT1, SCN1A, KCNH1, MEF2C, F2R, CACNA2D3, ACTN4, ATP1B2, ATP1B1, GEM, KCNQ1, KCNE3, KCNE4, HVCN1, ADRB2, CACNA1F, CORO1A, CD19, SCN3A, DRD4, LYN, TGFB1, CAV1, CXCL10, CXCL11, FXYD6, KCNK5, CXCL9, CTSS, GRM5, JPH2, PDE4B, KCND2, TRPC1, MMP9, DNM2, TMEM37, XCL1, NLGN1, PTAFR, KCNA5, PLN, FLNA, DMD, KCNJ15, KCNJ16, TSPAN13, GOPC, F2RL3]
GO:0098914;membrane repolarization during atrial cardiac muscle cell action potential;9.0;1.0;0.896240625180289;9.628524252492122;124.80295429285788;8.16763571524637;0.00417704256481522;0.8139338954918922;[KCNQ1, KCNA5]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, PYCARD, TCL1A, AKT1, CHI3L1, XCL1, CCL13, CALCA, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, CCL20, NFKB1]
GO:0050930;induction of positive chemotaxis;8.0;1.0;0.875;9.628524252492122;129.39753142075796;7.138016298065211;0.004330818926435078;0.7400384854347593;[CXCL12, NTF3, AZU1]
GO:0030049;muscle filament sliding;6.0;1.0;0.8231203125901445;9.628524252492122;20.959081145343944;6.139487467954083;7.014815839862524E-4;0.6370939872166814;[TPM2, TPM1, DMD]
GO:1900087;positive regulation of G1/S transition of mitotic cell cycle;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;354.40743100732976;6.409777797693995;0.011861697769835146;0.7240369598395108;[ANXA1, KCNA5, CDC6]
GO:0044267;cellular protein metabolic process;5.0;0.3358520568840654;0.45816704030295297;5.574370570853267;80.86766357206795;1.6585685600933726;0.0027065679235849286;0.3750602851554211;[, POP5, SLA2, AKT1, DUSP2, DUSP1, DUSP6, IL12RB2, PKN1, KCNH1, FBXW2, BLK, PKMYT1, NAE1, BMX, HM13, EIF4H, IL2RB, EIF3F, C1GALT1C1, TNFSF11, SNRPD3, ALG8, BTC, BTK, NAIP, SDC2, EGR2, PTK2, MUC15, SPTAN1, IL1B, KIT, PCNA, NDUFAB1, UBE2M, TNFAIP3, GHR, SPOCK3, TEK, PRDM16, ST3GAL6, IGHA1, BARD1, PLK2, ASGR1, ASGR2, CIT, GSN, ELP4, NUCB1, IL5RA, TNF, FGF5, LAMP2, MAP2K2, VRK1, NRBP1, COPS5, CCDC22, LAT, GAL3ST1, TPTE, NLRC4, TTR, PPIL4, PPP2R1A, ESCO2, POR, SIK1, PRL, ZDHHC17, TLR7, TLR4, TLR2, QPCT, NLRP3, CBX4, EIF2S1, KDM5D, LTF, HIST1H2BK, BUB1, WEE1, EHMT2, MYLK, KRTCAP2, MEF2C, PADI2, PADI4, IQGAP3, LYN, ABCA1, HACE1, LYZ, EZH2, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, USP9Y, PSMC6, PSMC2, F13A1, RUVBL1, AP2M1, S100A8, FOXO1, NFKB1, PTPRE, ST6GALNAC2, LRRK2, UTY, DSP, CCL8, CCL5, CCL2, TIE1, CCNH, EPHB1, PAQR3, ALPK2, EPHA3, PTPRR, FKBP14, PTPRK, BRCA2, CTSG, CCR5, PAK1, PRKY, PPP1CA, GXYLT2, PDGFRB, CCNE1, CALCA, KLHL14, PSMD14, PSEN2, RASGRP4, TAF9, GALNT7, GALNT6, EGF, CDK14, ANXA1, HBEGF, FAM105A, GTF2H1, CHRM1, ABHD12, GRAP2, MACROD2, STK32B, MEN1, MELK, NACC2, IGFBP7, WFS1, MARCH3, MARCH1, RNF24, CHEK1, SKP2, BCL11A, MAP4K1, B3GNT5, SGK1, RANBP2, CAMK4, GALNT14, ARID4A, FBL, CSF2RB, ADRB2, TGFB1, NFKBIA, TGFBR3, NCAM1]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[CYFIP1, SLA2, EPS8, STMN1, AKT1, EPHB1, BTC, BTK, EPHA3, SDC2, TGFA, SLC30A10, FLRT2, PDGFD, PDGFC, LYN, PTK2, NRP1, PTPRR, NRP2, CD3E, GAB1, KIT, HBEGF, PAK1, NTF3, SORT1, SORBS1, SULF2, NCF4, CTGF, FGF5, GRAP2, AP2M1, PDGFRB, TSC2, KIF16B, BLK, RASGRP4, FOXO1, STAP1, TGFB1, CAV2, CRIM1, BMX, GH1, CSPG4, GHR, BLNK, MMP9, ESRP1, REPS2, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, TRAT1, EGF, CD4, CD7, TEK]
GO:0051481;negative regulation of cytosolic calcium ion concentration;11.0;0.9326813400603323;0.8987696223598284;9.57973408832269;290.3013502407617;7.004484905440688;0.00971612493830514;0.7906386361357586;[KCNA5, SLC8A1]
GO:0006874;cellular calcium ion homeostasis;9.0;0.6324783794010864;0.7124798148808322;8.83001655627435;287.08247441589424;3.7781370657337865;0.009608392061246992;0.5894547304232562;[CXCL13, SLC8A1, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, F2R, ATP1B1, AGTR1, CALCA, C5AR1, FPR1, FPR3, FPR2, PKHD1, CD19, HRH4, ELANE, CCR10, DRD4, CCR1, TGFB1, WFS1, CAV1, CXCL10, CXCL11, CXCL12, CD24, GPR18, CXCL9, ATP2A3, FASLG, GRM5, JPH2, CCR9, CCR6, CD36, CCR5, CCR2, TRPC7, CD52, PTGIR, TRPC3, TRPC1, AVPR1A, IL1B, XCL1, CX3CR1, SLC24A2, SLC24A1, CCL13, SLC24A4, PTGER2, CXCR5, CXCR4, KCNA5, CXCR6, CCL8, PLN, CXCR1, CCL7, SV2A, CCL5, CXCR2, S1PR3, CCL1, CCL19, GPR157, CCL23, TMEM64, GPR6, P2RX5, CD4, GRINA, F2RL3]
GO:0048747;muscle fiber development;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;33.944966077546525;5.75172193694532;0.001136107466129388;0.6172636399279519;[CXADR, CAV2, MYH11, DMD]
GO:0002027;regulation of heart rate;7.0;0.7043150770688792;0.7030769037916401;8.712233520617966;26.867502833526505;5.233778845410465;8.992311406554274E-4;0.6185750588070984;[CALCA, KCNE3, KCNA5, SLC8A1, PLN, DMD, DSP, JUP, GCH1, CAV1, TPM1, TACR3, AVPR1A, MC3R, KCNQ1]
GO:0014809;regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion;11.0;0.8933024483968273;0.8790801765280758;9.566003895510788;202.48397571523563;8.16763571524637;0.0067769564434417605;0.8501222226412654;[DMD]
GO:0002548;monocyte chemotaxis;7.0;1.0;0.8509193652572005;9.628524252492122;125.46101547564297;6.039404009397101;0.004199067280386423;0.6597747671587765;[CCL13, CCL23, CALCA, ANXA1, CCL20, TNFRSF11A, LGALS3, CCL8, CCL7, CCL5, CCL4, TNFSF11, CCL2, XCL1, CCL1, CCL19, CCL18, IL6R, CCR2]
GO:0035725;sodium ion transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;113.92400819162063;5.014899692882714;0.0038129340292226534;0.6314622035107071;[SLC24A2, SLC24A1, SLC24A4, SLC8A1, SCN3A, SLC17A3, SCN1A, SLC13A1, SLC6A16, SLC6A15, SLC12A1, SLC6A13, ATP1B2, ATP1B1, SLC6A6, CAPS2]
GO:0030279;negative regulation of ossification;5.0;0.8436909121759173;0.712086467948879;9.377209824211215;41.83246312675316;5.500407508664414;0.0014000948940798496;0.571532107649126;[CALCA, TNF, MEN1, CCR1, MEF2C, TGFB1, TMEM64]
GO:0031645;negative regulation of neurological system process;6.0;0.7586651285174919;0.7024528768488905;8.874752450115741;45.20834270043467;6.686031174322154;0.0015130825453166033;0.665044257777226;[CALCA, LRRK2, AVPR1A]
GO:0070778;L-aspartate transmembrane transport;11.0;0.8933024483968273;0.8790801765280758;9.54514264355307;340.92125060540315;7.9853141584524145;0.011410327448557038;0.8407982897480031;[SLC1A3, SLC1A6]
